Literature DB >> 32211949

Adjunctive hydrodissection of the bare area of liver during percutaneous thermal ablation of sub-cardiac hepatic tumours.

Julien Garnon1,2, Roberto Luigi Cazzato3, Pierre Auloge3, Nitin Ramamurthy4, Guillaume Koch3, Afshin Gangi3.   

Abstract

OBJECTIVE: To report the technique of hydrodissection of the sub-diaphragmatic bare area of the liver, in order to protect the diaphragm/heart during percutaneous thermal ablation (PTA) of sub-cardiac hepatic tumours.
MATERIALS AND METHODS: Between January 2016 and December 2018, five patients (four female, one male; mean age 56.2 years) with five sub-cardiac liver tumours (two hepatocellular carcinoma, three metastases; mean size 39 mm) abutting the bare area (segments II/IVA) with expected ablation zones ≤ 5 mm from the myocardium were treated with PTA and adjunctive hydrodissection. Time to perform hydrodissection, distance between superior hepatic and diaphragmatic/pericardial surfaces before and after hydrodissection, ablation efficacy, complications, and local tumour progression (LTP) at last imaging follow-up were recorded.
RESULTS: Technical feasibility was 100%, with mean hydrodissection-volume of 126 ml (range 80-200 ml) and median hydrodissection-time of 9 min (range 8-45 min). Liver-diaphragmatic and liver-pericardial distance increased, respectively, from 2.4 mm (range 0-8 mm) to 10.8 mm (range 6-19 mm) and from 4 mm (range 1-10 mm) to 12.6 mm (range 8-20 mm) post-hydrodissection. All procedures were performed at full-power with complete tumour ablation and without complications (including peri-procedural haemodynamic/electrocardiographic disturbances, pericardial effusion and diaphragmatic hernia) or evidence of LTP at mean 12.2-month (range 1-26 month) follow-up.
CONCLUSION: Hydrodissection of the sub-diaphragmatic bare area of the liver is technically feasible and may potentially optimize safety PTA of sub-cardiac hepatic tumours.

Entities:  

Keywords:  Bare area of the liver; Heart; Hydrodissection; Thermal ablation

Mesh:

Year:  2020        PMID: 32211949     DOI: 10.1007/s00261-020-02463-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  18 in total

1.  Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.

Authors:  Dong Ik Cha; Tae Wook Kang; Kyoung Doo Song; Min Woo Lee; Hyunchul Rhim; Hyo Keun Lim; Dong Hyun Sinn; Kyunga Kim
Journal:  Eur Radiol       Date:  2018-11-30       Impact factor: 5.315

2.  Safety and Efficacy of Percutaneous Microwave Hepatic Ablation Near the Heart.

Authors:  George A Carberry; Amanda R Smolock; Mircea Cristescu; Shane A Wells; Timothy J Ziemlewicz; Meghan G Lubner; J Louis Hinshaw; Christopher L Brace; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2017-02-10       Impact factor: 3.464

3.  Radioanatomy of the retroperitoneal space.

Authors:  A Coffin; I Boulay-Coletta; D Sebbag-Sfez; M Zins
Journal:  Diagn Interv Imaging       Date:  2014-12-26       Impact factor: 4.026

Review 4.  Adjunctive Thermoprotection During Percutaneous Thermal Ablation Procedures: Review of Current Techniques.

Authors:  Julien Garnon; Roberto Luigi Cazzato; Jean Caudrelier; Maud Nouri-Neuville; Pramod Rao; Emanuele Boatta; Nitin Ramamurthy; Guillaume Koch; Afshin Gangi
Journal:  Cardiovasc Intervent Radiol       Date:  2018-10-11       Impact factor: 2.740

5.  Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective.

Authors:  Amanda R Smolock; Meghan G Lubner; Timothy J Ziemlewicz; J Louis Hinshaw; Douglas R Kitchin; Christopher L Brace; Fred T Lee
Journal:  AJR Am J Roentgenol       Date:  2015-01       Impact factor: 3.959

6.  Safety and Efficacy of Percutaneous Cryoablation for Small Hepatocellular Carcinomas Adjacent to the Heart.

Authors:  Joon Ho Kwon; Jong Yun Won; Kichang Han; Seungchul Han; Doyoung Kim; Heejoon Kim; Gyoung Min Kim; Man-Deuk Kim; Do Yun Lee
Journal:  J Vasc Interv Radiol       Date:  2019-04-05       Impact factor: 3.464

Review 7.  Artificial ascites and pneumoperitoneum to facilitate thermal ablation of liver tumors: a pictorial essay.

Authors:  Sharath K Bhagavatula; Jeffrey F B Chick; Nikunj R Chauhan; Paul B Shyn
Journal:  Abdom Radiol (NY)       Date:  2017-02

8.  Safety and Efficacy of Percutaneous Thermal Ablation of Juxta-Cardiac Hepatic Tumours.

Authors:  Justin Kwan; Chinthaka Appuhamy; Gavin Hock Tai Lim; Ivan Kuang Hsin Huang; Lawrence Quek; Uei Pua
Journal:  Cardiovasc Intervent Radiol       Date:  2018-03-26       Impact factor: 2.740

9.  Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.

Authors:  Peter Schullian; Daniel Putzer; Gregor Laimer; Elliot Levy; Reto Bale
Journal:  Eur Radiol       Date:  2019-09-05       Impact factor: 5.315

10.  Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy.

Authors:  Tae Wook Kang; Hyunchul Rhim; Eun Young Kim; Young Sun Kim; Dongil Choi; Won Jae Lee; Hyo K Lim
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

View more
  1 in total

1.  Artificial ascites using the guidewire technique during microwave ablation in the liver dome: technique and analysis of fluid repartition.

Authors:  Louis Delmas; Guillaume Koch; Roberto Luigi Cazzato; Julia Weiss; Pierre Auloge; Danoob Dalili; Pierre de Marini; Afshin Gangi; Julien Garnon
Journal:  Abdom Radiol (NY)       Date:  2021-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.